Regulatory Attorney Says Cybersecurity Moves Too Quickly for Effective Rulemaking, BioWorld MedTech

BioWorld MedTech speaks with life sciences partner Michele Buenafe about the FDA’s recent cybersecurity risk framework.

Read the full article.
(subscription may be required)